Noetic Fund, a venture fund based in Toronto, Canada, focuses on investing in early-stage psychedelic-based wellness, therapeutic, and pharmaceutical companies. With a fund stage that includes Pre-Seed, Seed, and Series A, Noetic Fund has made 10 investments and seen 1 exit so far. The fund is led by partner David Rabin and has Apollo Neuroscience in its portfolio. For more information, visit their website at noeticfund.com.